EUVIMEDEUVIMED entdecken
Crossref

Spinal cord-sparing directional palladium-103 brachytherapy for dose escalation to posterior vertebral structures: A cadaveric feasibility study

Tugce Kutuk, Seth Wilson, Michael Degnan, Nathan Ritchey, Jacob Ward, Mark Damante, Marshall Harrell, Alexander Crum, Raju Raval, Raj Singh, Fatemeh Fekrmandi, Khaled Dibs und 5 weitere

Journal of Contemporary Brachytherapy · 2026

DOI: 10.5114/jcb.2026.165746 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Contemporary Brachytherapy, 2026. Verfasst von Tugce Kutuk und 16 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spinal cord-sparing directional palladium-103 brachytherapy for dose escalation to posterior vertebral structures: A cadaveric feasibility study Tugce Kutuk 1 , Seth B. Wilson 2 , Michael Degnan 1 , Nathan Ritchey 2 , Jacob Ward 2 , Mark Damante 3 , Marshall Harrell 1 , Alexander Crum 1 , Raju Raval 1 , Raj Singh 4 , Fatemeh Fekrmandi 1 , Khaled Dibs 1 , Samantha Morelli 1 , Daniel Schneider 3 , Brian Park 3 , Vikram Chakravarthy 3 , Joshua Palmer 1 Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USA The Ohio State College of Medicine, Columbus, OH, USA Department of Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA Department of Radiation Oncology, Lynn Cancer Institute, Baptist Health South Florida, Boca Raton, FL, USA J Contemp Brachytherapy 2026 DOI: https://doi.org/10.5114/jcb.2026.165746 Online publish date: 2026/11/02 View full text Get citation Get citation ENW EndNote BIB JabRef, Mendeley RIS Papers, Reference Manager, RefWorks, Zotero AMA Kutuk T, Wilson SB, Degnan M, et al. Spinal cord-sparing directional palladium-103 brachytherapy for dose escalation to posterior vertebral structures: A cadaveric feasibility study. Journal of Contemporary Brachytherapy. 2026. doi:10.5114/jcb.2026.165746. APA Kutuk, T., Wilson, S. B., Degnan, M., Ritchey, N., Ward, J., & Damante, M. et al. (2026). Spinal cord-sparing directional palladium-103 brachytherapy for dose escalation to posterior vertebral structures: A cadaveric feasibility study. Journal of Contemporary Brachytherapy. https://doi.org/10.5114/jcb.2026.165746 Chicago Kutuk, Tugce, Seth B Wilson, Michael Degnan, Nathan Ritchey, Jacob Ward, Mark Damante, and Marshall Harrell et al. 2026. "Spinal cord-sparing directional palladium-103 brachytherapy for dose escalation to posterior vertebral structures: A cadaveric feasibility study". Journal of Contemporary Brachytherapy. doi:10.5114/jcb.2026.165746. Harvard Kutuk, T., Wilson, S., Degnan, M., Ritchey, N., Ward, J., Damante, M., Harrell, M., Crum, A., Raval, R., Singh, R., Fekrmandi, F., Dibs, K., Morelli, S., Schneider, D., Park, B., Chakravarthy, V., and Palmer, J. (2026). Spinal cord-sparing directional palladium-103 brachytherapy for dose escalation to posterior vertebral structures: A cadaveric feasibility study. Journal of Contemporary Brachytherapy. https://doi.org/10.5114/jcb.2026.165746 MLA Kutuk, Tugce et al. "Spinal cord-sparing directional palladium-103 brachytherapy for dose escalation to posterior vertebral structures: A cadaveric feasibility study." Journal of Contemporary Brachytherapy, 2026. doi:10.5114/jcb.2026.165746. Vancouver Kutuk T, Wilson S, Degnan M, Ritchey N, Ward J, Damante M et al. Spinal cord-sparing directional palladium-103 brachytherapy for dose escalation to posterior vertebral structures: A cadaveric feasibility study. Journal of Contemporary Brachytherapy. 2026. doi:10.5114/jcb.2026.165746. IntroductionRadiation dose escalation to the dorsal vertebral body (DVB) and pedicles is often limited by the proximity of spinal cord and cauda equina, resulting in sub-optimal target coverage. Directional low-dose-rate (LDR) palladium-103 (103Pd) membrane brachytherapy devices (MBDs) incorporate gold-shielded sources that enable anisotropic radiation delivery and facilitate selective dose escalation. This study evaluated the feasibility and dosimetric characteristics of anterior epidural placement of a directional 103Pd MBD in a cadaveric spine model. Material and methodsCustom-contoured 103Pd MBDs were implanted within the ventral epidural space at thoracic and lumbar levels in a human cadaver under fluoroscopic guidance. Device orientation, source geometry, and 0.8 cm source spacing were maintained to preserve directional dose emission. Post-implant CT and MRI were performed to assess device visualization and imaging artifact. Dosimetric analysis was conducted using Eclipse™ BrachyVision™ with AAPM TG-43 formalism to evaluate dose distributions to the DVB, pedicles, spinal cord, and cauda equina. ResultsImplantation was successfully performed at both spinal levels, with stable positioning and appropriate orientation of the gold-shielded surface to adjacent neural structures. CT and MRI demonstrated excellent device visualization, accurate source reconstruction, and minimal imaging artifact. A prescription dose of 47 Gy at 5 mm achieved ≥ 90% isodose coverage of the DVB and pedicles. Maximum doses to the spinal cord and cauda equina were limited to 9.2 Gy and 3.5 Gy, respectively. Directional shielding produced > 60% attenuation across the shielded plane, resulting in substantial neural sparing while maintaining target coverage. ConclusionsAnterior epidural placement of a directional 103Pd MBD is technically feasible, providing highly conformal irradiation of posterior vertebral structures while maintaining low doses to adjacent neural tissues. This approach may represent a novel strategy for overcoming spinal cord dose constraints and facilitating selective dose escalation in the management of spinal tumors. Keywords spine metastases, directional brachytherapy, palladium-103, anisotropic low-dose-rate (LDR) implant, spinal cord sparing

Zitieren

APA

Kutuk, T., Wilson, S., Degnan, M., Ritchey, N., Ward, J., Damante, M., Harrell, M., Crum, A., Raval, R., Singh, R., Fekrmandi, F., Dibs, K., Morelli, S., Schneider, D., Park, B., Chakravarthy, V., & Palmer, J. (2026). Spinal cord-sparing directional palladium-103 brachytherapy for dose escalation to posterior vertebral structures: A cadaveric feasibility study. Journal of Contemporary Brachytherapy. https://doi.org/10.5114/jcb.2026.165746

Vancouver

Kutuk T, Wilson S, Degnan M, Ritchey N, Ward J, Damante M, et al. Spinal cord-sparing directional palladium-103 brachytherapy for dose escalation to posterior vertebral structures: A cadaveric feasibility study. Journal of Contemporary Brachytherapy. 2026. doi:10.5114/jcb.2026.165746

BibTeX
@article{Kutuk2026,
  author = {Kutuk, Tugce and Wilson, Seth and Degnan, Michael and Ritchey, Nathan and Ward, Jacob and Damante, Mark and Harrell, Marshall and Crum, Alexander and Raval, Raju and Singh, Raj and Fekrmandi, Fatemeh and Dibs, Khaled and Morelli, Samantha and Schneider, Daniel and Park, Brian and Chakravarthy, Vikram and Palmer, Joshua},
  title = {Spinal cord-sparing directional palladium-103 brachytherapy for dose escalation to posterior vertebral structures: A cadaveric feasibility study},
  journal = {Journal of Contemporary Brachytherapy},
  year = {2026},
  doi = {10.5114/jcb.2026.165746}
}
Kostenlos starten →